• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall BLAST Bandage

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
  Class 2 Device Recall BLAST Bandage see related information
Date Initiated by Firm April 17, 2018
Create Date July 25, 2018
Recall Status1 Terminated 3 on July 22, 2020
Recall Number Z-2538-2018
Recall Event ID 80157
Product Classification Bandage, elastic - Product Code FQM
Product BLAST Bandage, sterile.
Code Information Lot 0617
Recalling Firm/
Manufacturer
Tactical Medical Solutions, Inc.
1250 Harris Bridge Rd
Anderson SC 29621-3409
For Additional Information Contact
864-224-0081
Manufacturer Reason
for Recall
Blast Bandages (part# BLAST) with Lot# 0617 were not terminally sterilized.
FDA Determined
Cause 2
Mixed-up of materials/components
Action Customers were notified on 04/17/2018 via letter and email. Instructions included to review bandages in inventory for affected lot, contact Tactical Medical to arrange replacement, complete and return the Acknowledgement and Receipt Form.
Quantity in Commerce 1,097 units
Distribution Domestic distribution to AL, AP, AZ, CA, CO, CT, DC, FL, GA, ID, IL, IN, KS, KY, MA, MD, ME, MI, MO, MS, NC, ND, NM, NY, OH, PA, SC, TX, VA, WI. International distribution to Austria, Canada, France, Kenya, Latvia, Netherlands, New Zealand, Poland, Singapore, South Africa, Switzerland, Turkey, United Kingdom.
Total Product Life Cycle TPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
-
-